Clinical Trial Update: A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With Anxiety [Phase 3]

View source ↗

Summary

Phase 3 multicenter open-label randomized crossover trial comparing alprazolam orally disintegrating tablets to conventional alprazolam tablets to assess subjec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• alprazolam orally disintegrating tablet (alprazolam)
• alprazolam tablet (alprazolam)

Snippet

Sponsor: UCB Pharma | Conditions: ANXIETY | Phase 3 | Status: COMPLETED